How does GILD's decision to license Indian generic companies affect opportunities in the far east? IMO, it will be a struggle to get non-generic pricing in China.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.